Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,029 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwé CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL. van Pareren YK, et al. Among authors: jansen m. J Clin Endocrinol Metab. 2003 Mar;88(3):1119-25. doi: 10.1210/jc.2002-021171. J Clin Endocrinol Metab. 2003. PMID: 12629094 Free article. Clinical Trial.
Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A. Van Pareren Y, et al. Among authors: jansen m. J Clin Endocrinol Metab. 2003 Aug;88(8):3584-90. doi: 10.1210/jc.2002-021172. J Clin Endocrinol Metab. 2003. PMID: 12915640 Free article. Clinical Trial.
Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty.
van Gool SA, Kamp GA, Visser-van Balen H, Mul D, Waelkens JJ, Jansen M, Verhoeven-Wind L, Delemarre-van de Waal HA, de Muinck Keizer-Schrama SM, Leusink G, Roos JC, Wit JM. van Gool SA, et al. Among authors: jansen m. J Clin Endocrinol Metab. 2007 Apr;92(4):1402-8. doi: 10.1210/jc.2006-2272. Epub 2007 Feb 6. J Clin Endocrinol Metab. 2007. PMID: 17284626 Clinical Trial.
Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
Willemsen RH, Arends NJ, Bakker-van Waarde WM, Jansen M, van Mil EG, Mulder J, Odink RJ, Reeser M, Rongen-Westerlaken C, Stokvis-Brantsma WH, Waelkens JJ, Hokken-Koelega AC. Willemsen RH, et al. Among authors: jansen m. Clin Endocrinol (Oxf). 2007 Oct;67(4):485-92. doi: 10.1111/j.1365-2265.2007.02913.x. Epub 2007 Jun 11. Clin Endocrinol (Oxf). 2007. PMID: 17561977 Clinical Trial.
Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen M, Delemarre-van de Waal HA, Stokvis-Brantsma WH, Waelkens JJ, Westerlaken C, Reeser HM, van Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM. Menke LA, et al. Among authors: jansen m. J Clin Endocrinol Metab. 2010 Mar;95(3):1151-60. doi: 10.1210/jc.2009-1821. Epub 2010 Jan 8. J Clin Endocrinol Metab. 2010. PMID: 20061421 Clinical Trial.
Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Delemarre-van de Waal HA, Vulsma T, Wit JM, Rouwé CW, Reeser HM, Gosen JJ, Rongen-Westerlaken C, Drop SL. van Teunenbroek A, et al. Among authors: jansen m. J Clin Endocrinol Metab. 1996 Nov;81(11):4013-21. doi: 10.1210/jcem.81.11.8923853. J Clin Endocrinol Metab. 1996. PMID: 8923853 Clinical Trial.
Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
van Teunenbroek A, de Muinck Keizer-Schrama S, Stijnen T, Waelkens J, Wit JM, Vulsma T, Gerver WJ, Reeser H, Delemarre-van de Waal H, Jansen M, Drop S. van Teunenbroek A, et al. Among authors: jansen m. Clin Endocrinol (Oxf). 1997 Apr;46(4):451-9. doi: 10.1046/j.1365-2265.1997.1610972.x. Clin Endocrinol (Oxf). 1997. PMID: 9196608 Clinical Trial.
Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, Hokken-Koelega AC, Waelkens JJ, Massa GG, Vulsma T, Gerver WJ, Reeser HM, Delemarre-van de Waal HE, Jansen M, Drop SL. Sas TC, et al. Among authors: jansen m. Arch Dis Child. 1999 Jan;80(1):36-41. doi: 10.1136/adc.80.1.36. Arch Dis Child. 1999. PMID: 10325756 Free PMC article. Clinical Trial.
2,029 results